566
Views
9
CrossRef citations to date
0
Altmetric
Review

Emerging trends in microneedle-based drug delivery strategies for the treatment of rheumatoid arthritis

ORCID Icon, , , , ORCID Icon, & ORCID Icon show all
Pages 395-407 | Received 04 Jan 2022, Accepted 11 Mar 2022, Published online: 23 Mar 2022

References

  • He Y, Majid K, Maqbool M, et al. Formulation and characterization of lornoxicam-loaded cellulosic-microsponge gel for possible applications in arthritis. Saudi Pharm J. 2020;28(8):994–1003.
  • Chuang SY, Lin CH, Huang TH, et al. Lipid-based nanoparticles as a potential delivery approach in the treatment of rheumatoid arthritis. Nanomaterials. 2018;8(1):42.
  • Shende P, Salunke M. Transepidermal microneedles for co-administration of folic acid with methotrexate in the treatment of rheumatoid arthritis. Biomed Phys Eng Express. 2019;5(2):25023.
  • Arthritis - India: Dr. Shrikant Wagh. Available from: https://www.arthritis-india.com
  • Gorantla S, Gorantla G, Saha RN, et al. CD44 receptor-targeted novel drug delivery strategies for rheumatoid arthritis therapy. Expert Opin Drug Deliv. 2021;18(11):1553–1557. Available from: https://pubmed.ncbi.nlm.nih.gov/34190674
  • Alunno A, Carubbi F, Giacomelli R, et al. Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets. BMC Rheumatol. 2017;1(1):1–13.
  • Qindeel M, Ullah MH, Din FU, et al. Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy. J Control Release. 2020;327:595–615.
  • Cao J, Zhang N, Wang Z, et al. Microneedle-assisted transdermal delivery of etanercept for rheumatoid arthritis treatment. Pharmaceutics. 2019;11(5):235. Available from: https://pubmed.ncbi.nlm.nih.gov/31096705
  • Nithyashree RS, Deveswaran R, Comprehensive A. Review on rheumatoid arthritis. J Pharm Res Int. 2020;32:18–32.
  • Rapalli VK, Mahmood A, Waghule T, et al. Revisiting techniques to evaluate drug permeation through skin. Expert Opin Drug Deliv. 2021;18(12):1829–1842. Available from:. https://www.tandfonline.com/doi/abs/10.1080/17425247.2021.2010702
  • Qiu Y, Li C, Zhang S, et al. Systemic delivery of artemether by dissolving microneedles. Int J Pharm. 2016;508(1–2):1–13.
  • Yao W, Tao C, Zou J, et al. Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin: a biocomfortable attempt to treat rheumatoid arthritis. Int J Pharm. 2019;563:91–100.
  • Gorantla S, Saha RN, Singhvi G. Spectrophotometric method to quantify tofacitinib in lyotropic liquid crystalline nanoparticles and skin layers: application in ex vivo dermal distribution studies. Spectrochim Acta - Part A Mol Biomol Spectrosc. 2021;255:119719.
  • Gorantla S, Dabholkar N, Sharma S, et al. Chitosan-based microneedles as a potential platform for drug delivery through the skin: trends and regulatory aspects. Int J Biol Macromol. 2021;184:438–453.
  • Guo T, Cheng N, Zhao J, et al. Novel nanostructured lipid carriers-loaded dissolving microneedles for controlled local administration of aconitine. Int J Pharm. 2019;572:118741.
  • Rapalli VK, Singhvi G. Dermato-pharmacokinetic: assessment tools for topically applied dosage forms.Expert Opin Drug Deliv. 2020;18(4):423–426.
  • Dabholkar N, Gorantla S, Waghule T, et al. Biodegradable microneedles fabricated with carbohydrates and proteins: revolutionary approach for transdermal drug delivery. Int J Biol Macromol. 2021;170:602–621.
  • Henry S, McAllister DV, Allen MG, et al. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci. 1998;87:922–925.
  • Gorantla S, Singhvi G, Rapalli VK, et al. Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status. Ther Deliv. 2020;11(4):269–284. Available from:. https://www.future-science.com/doi/10.4155/tde-2020-0029
  • Waghule T, Singhvi G, Dubey SK, et al. Microneedles: a smart approach and increasing potential for transdermal drug delivery system. Biomed Pharmacother. 2019;109:1249–1258.
  • Vargason AM, Anselmo AC, Mitragotri S. The evolution of commercial drug delivery technologies.Nat Biomed Eng. 2021;5(9):951–967.
  • Singhvi G, Hans N, Shiva N, et al. Xanthan gum in drug delivery applications. Nat Polysaccharides Drug Deliv Biomed Appl 2019; 121–144
  • Mir M, Permana AD, Ahmed N, et al. Enhancement in site-specific delivery of carvacrol for potential treatment of infected wounds using infection responsive nanoparticles loaded into dissolving microneedles: a proof of concept study. Eur J Pharm Biopharm. 2020;147:57–68.
  • Ruan S, Zhang Y, Feng N. Microneedle-mediated transdermal nanodelivery systems: a review. Biomater Sci. 2021;9(24):8065–8089. Available from: https://pubs.rsc.org/en/content/articlehtml/2021/bm/d1bm01249e
  • Guo T, Zhang Y, Li Z, et al. Microneedle-mediated transdermal delivery of nanostructured lipid carriers for alkaloids from Aconitum sinomontanum. Artif Cells Nanomed Biotechnol. 2018;46:1541–1551.
  • Shah UU, Roberts M, Orlu Gul M, et al. Needle-free and microneedle drug delivery in children: a case for disease-modifying antirheumatic drugs (DMARDs). Int J Pharm. 2011;416(1):1–11.
  • Tucak A, Sirbubalo M, Hindija L, et al. Microneedles: characteristics, materials, production methods and commercial development. Micromachines. 2020;11(11):1–30.
  • Bhatnagar S, Gadeela PR, Thathireddy P, et al. Microneedle-based drug delivery: materials of construction. J Chem Sci. 2019;131(9):1–28.
  • Rapalli VK, Waghule T, Hans N, et al. Insights of lyotropic liquid crystals in topical drug delivery for targeting various skin disorders. J Mol Liq. 2020;315:113771.
  • Guillot AJ, Cordeiro AS, Donnelly RF, et al. Microneedle‐based delivery: an overview of current applications and trends. Pharmaceutics. 2020;12(6):1–28.
  • Thakur S, Riyaz B, Patil A, et al. Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: an overview. Biomed Pharmacother. 2018;106:1011–1023.
  • So JW, Park HH, Lee SS, et al. Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations. Drug Deliv. 2009;16(1):52–56.
  • Nagarkar R, Singh M, Nguyen HX, et al. A review of recent advances in microneedle technology for transdermal drug delivery. J Drug Deliv Sci Technol. 2020;59:101923.
  • Vučen SR, Vuleta G, Crean AM, et al. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles. J Pharm Pharmacol. 2013;65(10):1451–1462.
  • Chowdhury F. Teriparatide micro-patchTM: a solid microneedle product nearing clinical trials. ONdrugDelivery. 2018;2018:32–34.
  • Baek SH, Shin JH, Kim YC. Drug-coated microneedles for rapid and painless local anesthesia. Biomed Microdevices. 2017;19(1):1–9.
  • Davidson A, Al-Qallaf B, Das DB. Transdermal drug delivery by coated microneedles: geometry effects on effective skin thickness and drug permeability. Chem Eng Res Des. 2008;86(11):1196–1206.
  • Tarbox TN, Watts AB, Cui Z, et al. An update on coating/manufacturing techniques of microneedles. Drug Deliv Transl Res. 2018;8(6):1828–1843. Available from: https://pubmed.ncbi.nlm.nih.gov/29288358
  • Ita K. Ceramic microneedles and hollow microneedles for transdermal drug delivery: two decades of research. J Drug Deliv Sci Technol. 2018;44:314–322.
  • Bushra F Delivery of Denosumab via Hollow Microneedle. Diss. Brac University. 2020;1–41.
  • Gorantla S, Saha RN, Singhvi G. Exploring the affluent potential of glyceryl mono oleate – myristol liquid crystal nanoparticles mediated localized topical delivery of Tofacitinib: study of systematic QbD, skin deposition and dermal pharmacokinetics assessment. J Mol Liq. 2022;346:117053.
  • Cárcamo-Martínez Á, Mallon B, Anjani QK, et al. Enhancing intradermal delivery of tofacitinib citrate: comparison between powder-loaded hollow microneedle arrays and dissolving microneedle arrays. Int J Pharm. 2021;593:120152. Available from:. https://pure.qub.ac.uk/en/publications/enhancing-intradermal-delivery-of-tofacitinib-citrate-comparison-
  • Dangol M, Yang H, Li CG, et al. Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles. J Control Release. 2016;223:118–125.
  • Amodwala S, Kumar P, Thakkar HP. Statistically optimized fast dissolving microneedle transdermal patch of meloxicam: a patient friendly approach to manage arthritis. Eur J Pharm Sci. 2017;104:114–123.
  • Agrawal S, Gandhi SN, Gurjar P, et al. Microneedles: an advancement to transdermal drug delivery system approach. J Appl Pharm Sci. 2020;10:149–159.
  • Cui Y, Mo Y, Zhang Q, et al. Microneedle-assisted percutaneous delivery of paeoniflorin-loaded ethosomes. Molecules. 2018;23(12):3371.
  • Zhang Y, Hu H, Jing Q, et al. Improved biosafety and transdermal delivery of aconitine via diethylene glycol monoethyl ether-mediated microemulsion assisted with microneedles. Pharm. 2020;12:163. Available from: https://www.mdpi.com/1999-4923/12/2/163/htm
  • Shu Z, Cao Y, Tao Y, et al. Polyvinylpyrrolidone microneedles for localized delivery of sinomenine hydrochloride: preparation, release behavior of in vitro & in vivo, and penetration mechanism. Drug Deliv. 2020;27(1):642–651.
  • Wu X, Chen Y, Gui S, et al. Sinomenine hydrochloride-loaded dissolving microneedles enhanced its absorption in rabbits. Pharm Dev Technol. 2016;21(7):787–793.
  • Chen J, Huang W, Huang Z, et al. Fabrication of Tip-dissolving microneedles for transdermal drug delivery of meloxicam. AAPS PharmSciTech. 2018;19(3):1141–1151.
  • Qindeel M, Khan D, Ahmed N, et al. Surfactant-free, self-assembled nanomicelles-based transdermal hydrogel for safe and targeted delivery of methotrexate against rheumatoid arthritis. ACS Nano. 2020;14(4):4662–4681. [cited 2022 Feb 12]. Available from: https://pubs.acs.org/doi/abs/10.1021/acsnano.0c00364
  • Vemulapalli V, Yang Y, Friden PM, et al. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J Pharm Pharmacol. 2010;60(1):27–33.
  • Song X, Wang Y, Chen H, et al. Dosage-efficacy relationship and pharmacodynamics validation of brucine dissolving microneedles against rheumatoid arthritis. J Drug Deliv Sci Technol. 2021;63:102537.
  • Chen G, Hao B, Ju D, et al. Pharmacokinetic and pharmacodynamic study of triptolide-loaded liposome hydrogel patch under microneedles on rats with collagen-induced arthritis. Acta Pharm Sin B. 2015;5(6):569–576.
  • Tekko IA, Chen G, Domínguez-Robles J, et al. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate. Int J Pharm. 2020;586:119580.
  • Zhao M, Bai J, Lu Y, et al. Anti-arthritic effects of microneedling with bee venom gel. J Tradit Chinese Med Sci. 2016;3. 256–262.
  • Cao J, Su J, An M, et al. Novel DEK-targeting aptamer delivered by a hydrogel microneedle attenuates collagen-induced arthritis. Mol Pharm. 2021;18(1):305–316.
  • Li Y, Sun Y, Wei S, et al. Development and evaluation of tofacitinib transdermal system for the treatment of rheumatoid arthritis in rats. Drug Dev Ind Pharm. 2021;47(6):878–886.
  • Du G, He P, Zhao J, et al. Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment. J Control Release. 2021;336:537–548.
  • Hu H, Ruan H, Ruan S, et al. Acid-responsive PEGylated branching PLGA nanoparticles integrated into dissolving microneedles enhance local treatment of arthritis. Chem Eng J. 2022;431:134196.
  • Song H, Wen J, Li H, et al. Enhanced transdermal permeability and drug deposition of rheumatoid arthritis via sinomenine hydrochloride-loaded antioxidant surface transethosome. Int J Nanomedicine. 2019;14:3177–3188.
  • Adalimumab microneedles in healthy volunteers - clinicalTrials.gov.
  • Queiroz MLB, Shanmugam S, Santos LNS, et al., Microneedles as an alternative technology for transdermal drug delivery systems: a patent review. Expert Opin Ther Pat. 2020;30(6): 433–452.
  • Russell FR β device for delivery of rheumatoid arthritis medication. WO2011135530A2. 2011.
  • Yuzhakov VV Method of making microneedle array and device for applying microneedle array to skin. US8414548B2. 2013.
  • Morgan DP, Kontorvich B, Vordenberg S Systems for administering medication for patients with rheumatoid arthritis. ES2679674T3. 2018.
  • Combination product definition combination product types | FDA.
  • Regulatory considerations for microneedling products | FDA.
  • Vaidya J, Shende P. Potential of sonophoresis as a skin penetration technique in the treatment of rheumatoid arthritis with transdermal patch. AAPS PharmSciTech. 2020;21(5):1–9.
  • Dugam S, Tade R, Dhole R, et al. Emerging era of microneedle array for pharmaceutical and biomedical applications: recent advances and toxicological perspectives. Futur J Pharm Sci. 2021;7(1):1–26. [cited 2022 Feb 12]. Available from: https://fjps.springeropen.com/articles/10.1186/s43094-020-00176-1
  • Why the consistent challenges surrounding maps are dissolving fast - ONdrugDelivery. [cited 2022 Feb 12]. Available from: https://ondrugdelivery.com/why-the-consistent-challenges-surrounding-maps-are-dissolving-fast

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.